Yandong Shen

595 total citations
29 papers, 396 citations indexed

About

Yandong Shen is a scholar working on Genetics, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Yandong Shen has authored 29 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Genetics, 10 papers in Immunology and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Yandong Shen's work include Chronic Lymphocytic Leukemia Research (21 papers), Immunodeficiency and Autoimmune Disorders (7 papers) and Lymphoma Diagnosis and Treatment (5 papers). Yandong Shen is often cited by papers focused on Chronic Lymphocytic Leukemia Research (21 papers), Immunodeficiency and Autoimmune Disorders (7 papers) and Lymphoma Diagnosis and Treatment (5 papers). Yandong Shen collaborates with scholars based in Australia, China and Ireland. Yandong Shen's co-authors include Stephen P. Mulligan, Kaifeng Gan, Giles Best, Keqi Hu, Dingli Xu, Lingxiao Pan, Richard I. Christopherson, Ke Zhou, Wei Wu and Ting Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and British Journal of Haematology.

In The Last Decade

Yandong Shen

28 papers receiving 392 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yandong Shen Australia 11 118 84 82 79 78 29 396
Katja Sockel Germany 12 196 1.7× 12 0.1× 17 0.2× 87 1.1× 77 1.0× 51 526
Shin-Hyung Park South Korea 13 35 0.3× 9 0.1× 136 1.7× 27 0.3× 93 1.2× 39 460
Dayang Hui China 8 66 0.6× 7 0.1× 79 1.0× 51 0.6× 116 1.5× 13 285
Claire Owen Australia 10 114 1.0× 9 0.1× 33 0.4× 20 0.3× 19 0.2× 40 437
Peter Ntiamoah United States 11 18 0.2× 9 0.1× 46 0.6× 29 0.4× 199 2.6× 27 418
Xiangui Peng China 12 138 1.2× 5 0.1× 33 0.4× 69 0.9× 126 1.6× 50 434
Marcus M. Kessler United States 8 22 0.2× 7 0.1× 27 0.3× 102 1.3× 102 1.3× 13 391
Renee Frank United States 10 13 0.1× 12 0.1× 113 1.4× 37 0.5× 70 0.9× 13 289

Countries citing papers authored by Yandong Shen

Since Specialization
Citations

This map shows the geographic impact of Yandong Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yandong Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yandong Shen more than expected).

Fields of papers citing papers by Yandong Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yandong Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yandong Shen. The network helps show where Yandong Shen may publish in the future.

Co-authorship network of co-authors of Yandong Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Yandong Shen. A scholar is included among the top collaborators of Yandong Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yandong Shen. Yandong Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Yandong, Lauren A. Thurgood, Edwin J. Iwanowicz, et al.. (2024). The CIpP activator, TR-57, is highly effective as a single agent and in combination with venetoclax against CLL cells in vitro. Leukemia & lymphoma. 65(5). 585–597. 2 indexed citations
2.
Lew, Thomas E., Victor S. Lin, Sasanka M. Handunnetti, et al.. (2024). Venetoclax-rituximab is active in patients with BTKi-exposed CLL, but durable treatment-free remissions are uncommon. Blood Advances. 8(6). 1439–1443. 6 indexed citations
3.
4.
Shen, Yandong, et al.. (2023). Repeated COVID‐19 vaccination to maximum antibody response yields very low mortality and hospitalisation rates in patients with CLL and MBL. British Journal of Haematology. 204(2). 487–491. 2 indexed citations
5.
Shen, Yandong, Ian Kerridge, Anouschka Akerman, et al.. (2022). Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversion. Blood. 140(25). 2709–2721. 17 indexed citations
6.
Tang, Catherine, Yandong Shen, Asha Soosapilla, & Stephen P. Mulligan. (2022). Monoclonal B-cell Lymphocytosis – a review of diagnostic criteria, biology, natural history, and clinical management. Leukemia & lymphoma. 63(12). 2795–2806. 5 indexed citations
7.
Shen, Yandong, Asha Soosapilla, Catherine Tang, et al.. (2021). COVID‐19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B‐lymphocytosis; humoural and cellular immunity. British Journal of Haematology. 197(1). 41–51. 30 indexed citations
8.
9.
Shen, Yandong, Luke Coyle, Ian Kerridge, et al.. (2021). Second primary malignancies in chronic lymphocytic leukaemia: Skin, solid organ, haematological and Richter's syndrome. SHILAP Revista de lepidopterología. 3(1). 129–138. 14 indexed citations
10.
Thurgood, Lauren A., Yandong Shen, Richard I. Christopherson, et al.. (2020). Therapeutic approaches and drug-resistance in chronic lymphocytic leukaemia. Cancer Drug Resistance. 3(3). 532–549. 3 indexed citations
11.
Shen, Yandong, et al.. (2020). IBL-202 is synergistic with venetoclax in CLL under in vitro conditions that mimic the tumor microenvironment. Blood Advances. 4(20). 5093–5106. 4 indexed citations
12.
Gifford, Andrew J., et al.. (2020). Fatty acid synthase and adenosine monophosphate-activated protein kinase regulate cell survival and drug sensitivity in diffuse large B-cell lymphoma. Leukemia & lymphoma. 61(8). 1810–1822. 11 indexed citations
13.
Gan, Kaifeng, et al.. (2019). Dynamic Fixation Versus Static Fixation for Distal Tibiofibular Syndesmosis Injuries: A Meta-Analysis. Medical Science Monitor. 25. 1314–1322. 14 indexed citations
14.
Shen, Yandong, et al.. (2019). Venetoclax Is Synergistic with Idelalisib or MK2206 Against Primary CLL Cells in an in Vitro Model of the Microenvironment. Blood. 134(Supplement_1). 5443–5443. 4 indexed citations
15.
16.
17.
Shen, Yandong, Giles Best, Stephen P. Mulligan, & Richard I. Christopherson. (2017). Ibrutinib and idelalisib block immunophenotypic changes associated with the adhesion and activation of CLL cells in the tumor microenvironment. Leukemia & lymphoma. 59(8). 1927–1937. 7 indexed citations
18.
Gan, Kaifeng & Yandong Shen. (2017). Metastatic Pulmonary Adenocarcinoma of the Talus: A Case Report. The Journal of Foot & Ankle Surgery. 56(4). 827–831. 5 indexed citations
19.
Shen, Yandong, et al.. (2016). Modeling the chronic lymphocytic leukemia microenvironmentin vitro. Leukemia & lymphoma. 58(2). 266–279. 18 indexed citations
20.
Chen, Xiaosong, Mingang Hao, Xueqing Sun, et al.. (2013). Dual Inhibition of PI3K and mTOR Mitigates Compensatory AKT Activation and Improves Tamoxifen Response in Breast Cancer. Molecular Cancer Research. 11(10). 1269–1278. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katja Sockel Breakdown of academic impact, for papers by Shin-Hyung Park Breakdown of academic impact, for papers by Dayang Hui Breakdown of academic impact, for papers by Claire Owen Breakdown of academic impact, for papers by Peter Ntiamoah Breakdown of academic impact, for papers by Xiangui Peng Breakdown of academic impact, for papers by Marcus M. Kessler Breakdown of academic impact, for papers by Renee Frank
Rankless by CCL
2026